Gå till forskningen.

Publikationsdata från Europe PMC och PubMed. Följ källhänvisningar från ämnesregistret till originalpublikationerna.

Publikationer som ChEBI hänvisar till för 2-[[[1-(7-chloro-4-quinolinyl)-5-(2,6-dimethoxyphenyl)-3-pyrazolyl]-oxomethyl]amino]-2-adamantanecarboxylic acid. Visa hela publikationsregistret

En publikationsträff är inte en slutsats. Publikationslistan visar bibliografiska uppgifter. Eventuella forskningsutdrag visas separat med originalunderlag. En källhänvisning visar inte i sig effekt, dosering eller säkerhet.

Publikationer i urvalet

9 träffar

Bibliografisk träff 2019-08-20

Discovery of β-Arrestin Biased, Orally Bioavailable, and CNS Penetrant Neurotensin Receptor 1 (NTR1) Allosteric Modulators.

Pinkerton AB, Peddibhotla S, Yamamoto F, Slosky LM, Bai Y, Maloney P, Hershberger P, Hedrick MP, Falter B, Ardecky RJ, Smith LH, Chung TDY, Jackson MR, Caron MG, Barak LS.

J Med Chem · research-article; journal article; research support, n.i.h., extramural · DOI 10.1021/acs.jmedchem.9b00340

Bibliografisk träff 2014-06-20

The discovery of indole full agonists of the neurotensin receptor 1 (NTSR1).

Di Fruscia P, He Y, Koenig M, Tabrizifard S, Nieto A, McDonald PH, Kamenecka TM.

Bioorg Med Chem Lett · research-article; journal article; research support, n.i.h., extramural · DOI 10.1016/j.bmcl.2014.06.033

Bibliografisk träff 2014-06-05

Identification of 1-({[1-(4-fluorophenyl)-5-(2-methoxyphenyl)-1H-pyrazol-3-yl]carbonyl}amino)cyclohexane carboxylic acid as a selective nonpeptide neurotensin receptor type 2 compound.

Thomas JB, Giddings AM, Wiethe RW, Olepu S, Warner KR, Sarret P, Gendron L, Longpre JM, Zhang Y, Runyon SP, Gilmour BP.

J Med Chem · research-article; journal article; research support, n.i.h., extramural · DOI 10.1021/jm5003843

Bibliografisk träff 2013-11-21

Imidazole-derived agonists for the neurotensin 1 receptor.

Hershberger PM, Hedrick MP, Peddibhotla S, Mangravita-Novo A, Gosalia P, Li Y, Gray W, Vicchiarelli M, Smith LH, Chung TD, Thomas JB, Caron MG, Pinkerton AB, Barak LS, Roth GP.

Bioorg Med Chem Lett · research-article; journal article; research support, n.i.h., extramural · DOI 10.1016/j.bmcl.2013.11.026

Bibliografisk träff 2013-05-06

The synthesis of neurotensin antagonist SR 48692 for prostate cancer research.

Baxendale IR, Cheung S, Kitching MO, Ley SV, Shearman JW.

Bioorg Med Chem · research support, non-u.s. gov't; journal article · DOI 10.1016/j.bmc.2013.04.075

Bibliografisk träff 2011-02-03

The many faces of the adamantyl group in drug design.

Liu J, Obando D, Liao V, Lifa T, Codd R.

Eur J Med Chem · research support, non-u.s. gov't; review; journal article · DOI 10.1016/j.ejmech.2011.01.047

Bibliografisk träff 2009-04-01

Comparison of N-terminal modifications on neurotensin(8-13) analogues correlates peptide stability but not binding affinity with in vivo efficacy.

Orwig KS, Lassetter MR, Hadden MK, Dix TA.

J Med Chem · comparative study; journal article; research support, n.i.h., extramural · DOI 10.1021/jm801072v

Bibliografisk träff 2009-01-15

The identification of nonpeptide neurotensin receptor partial agonists from the potent antagonist SR48692 using a calcium mobilization assay.

Thomas JB, Navarro H, Warner KR, Gilmour B.

Bioorg Med Chem Lett · comparative study; research support, non-u.s. gov't; research-article; journal article; research support, n.i.h., extramural · DOI 10.1016/j.bmcl.2009.01.024

Bibliografisk träff 2008-08-27

Novel insights into GPCR-peptide interactions: mutations in extracellular loop 1, ligand backbone methylations and molecular modeling of neurotensin receptor 1.

Härterich S, Koschatzky S, Einsiedel J, Gmeiner P.

Bioorg Med Chem · research support, non-u.s. gov't; journal article · DOI 10.1016/j.bmc.2008.08.051